Member Info for Darwen68

All you need to know is we have "a bullish doji star" apparently.

Now that investors have been pretty well shafted. I remember a degree of blackmail that a potential deal with Standigm Inc was dependant on the placing.

I wonder how long it will take to get any update.

They simply didn't have the speediacy to get the paraytec covid testing to market in time - at least in the mind of investors.
It is/always going to be a protracted development to attain the required accuracy and gain the required certifications.

He/she says we are filtered but he/she can't help themselves because of self importance.
"Sooner rather than later" he/she will have something to say - it will be nonsense but we are used to that.

Disappointed that the proof of concept for the sepsis testing is not further advanced.We now have to wait how it performs against a billion different bacteria.
Gosh what a lot of RNS's due.!!.

Scoter.
Although it's totally unvalidated and probably something you have made up.

ExMS.
Absolute nonsense.
Your covid figures are wrong,your winter flu figures. are wrong.

It is possible Phasefocus could be sold off - it is proven concept and is being used in the correct settings
I don't belive there is 70 suitors for Paraytec,I think this is TB/BRH in their "jam tomorrow" mode.
Granted it only takes one suitor but as I say little has been proven,certified or advanced apart from months and months of a twitter strap line.

Let's hope TB doesn't follow "deepmatter" and their placing at an 84% discount to the share price at the time.

Antha.
Liked to be proved wrong.
The alzheimer test was not successful,the need for covid is being rowed back (rightly or wrongly).
Sepsis and bladder cancer testing has not been proven,we have had the same patter from its developer for months.
Dr CS twitter is a combination of jam tomorrow and TB instruction.

I think we are going to find out that the science is not as compelling as we have been led to believe.

Or the science and prospects of are not as compelling as we are to believe.

TB can still sell at a profit,not many other people can say the same.
Carl's comment of "the paint is nearly dry" - a shame he forgot to mention it was the undercoat.

Unless of course the venues in question buy multiple analysers - as they probably would having multiple entrances.Then the multiples of turnaround can be much improved.What will be the defining issues will be upfront cost,running cost and ease of use for the untrained.

Thanks Twib.
Just thought that sometimes FOMO outflanked fundamentals.
Good to know.

Twib and others.
how relevent is "charting" in the realms of nnn ( or that matter,most of AIM).
do/can the charts take into accounts the world of ramping/deramping and FOMO.
taking the phrase "elephants can't jump" in the main markets,AIM stocks have the ability to fluctuate
wildly and i'd always assumed difficult to chart.
glad for any feedback.

Uddin.
All we need now is a CEO that can find his arse with both hands.

Come on twitter!!

We've acquired woolworths for the revolutionary pick 'n' mix

We're gonna need a cruise ship.

Although on the same premise of pump and dump it was possible to make good percentage gains at NNN then RMS and an excellent dividend was paid to shareholders in BRH as well.
Investing in the AIM market is a very lose term as it is the wild west of the stock market,you have to cope with pump and dumps,rampers,derampers,death spiral funding and management who could be elsewhere if they were better.
You tend to need either a crystal ball or simply time things with luck to make any gains.
The FCA aren't/won't be interested.